The document outlines various clinical quality performance indicators and goals for a healthcare organization. It provides data on metrics related to prenatal care access, low birth weights, weight assessment for children, adult weight screening, tobacco cessation, cancer screenings, immunizations, chronic disease management, and behavioral health. Charts show the organization's performance compared to national benchmarks and goals over time.
The presentation gives an overview on chlamydia among young Europeans and existing control activities in EU/EEA Member States. It refers to the ECDC Guidance on Chlamydia control that was published 2015 and outlines challenges to chlamydia control.
Presentation in the ECDC symposium at IUSTI Europe conference 2016, Budpaest, Hungary.
2014 trends survey of child health care professionals on Meningitis VaccinationsGRIVEAS ASSOCIATES
Between September and December 2014 we have conducted a global online survey to 45,000 children healthcare professionals to identify discrepancies and regional trends on everyday practice, compliance with guidelines, education gaps and preferred education sources in a number of areas including, HPV and Meningitis Vaccinations, Rare Diseases, Breastfeeding and Skincare.
667 healthcare experts, mostly general pediatricians (45.24%) responded from 84 countries. Most respondents were clinically active at general hospitals (29.89%), children’s hospitals (23.65%), private practice (18.7 %), university (17.77 %), and primary care (7.26%).
The presentation gives an overview on chlamydia among young Europeans and existing control activities in EU/EEA Member States. It refers to the ECDC Guidance on Chlamydia control that was published 2015 and outlines challenges to chlamydia control.
Presentation in the ECDC symposium at IUSTI Europe conference 2016, Budpaest, Hungary.
2014 trends survey of child health care professionals on Meningitis VaccinationsGRIVEAS ASSOCIATES
Between September and December 2014 we have conducted a global online survey to 45,000 children healthcare professionals to identify discrepancies and regional trends on everyday practice, compliance with guidelines, education gaps and preferred education sources in a number of areas including, HPV and Meningitis Vaccinations, Rare Diseases, Breastfeeding and Skincare.
667 healthcare experts, mostly general pediatricians (45.24%) responded from 84 countries. Most respondents were clinically active at general hospitals (29.89%), children’s hospitals (23.65%), private practice (18.7 %), university (17.77 %), and primary care (7.26%).
What is the current situation of HIV in Europe and Central Asia?
How can we more effectively prevent new infections?
Presentation by Anastasia Pharris,
European Centre for Disease Prevention and Control (ECDC)
at Glasgow HIV Drug Therapy Conference
28 October 2018
Interesting things about alcohol and other drugs - October 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
In the final ELC West of England series, we look back at the data we've collected over the past two years to show us how we, as a collaborative, have progressed.
As part of the IFPRI Egypt Seminar in partnership with the National Nutrition Committee: "the 100 million healthy lives initiative: Food availability, access and consumption patterns in Egypt"
Presentation by Teymur Noori, ECDC, at AIDS 2018 conference during teh joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
The Early Age Onset (EAO) Colorectal Cancer (CRC) Summit was a novel meeting designed for Early Age Onset (EAO) colorectal cancer (CRC) survivors, affected families as well as physicians and scientists who were interested in advancing their understanding of the rapidly increasing incidence of rectal and colon cancer among young adults under 50 years of age.
Co-hosted by the Colon Cancer Challenge Foundation and the CME office of Memorial Sloan Kettering Cancer Center the program provided an opportunity to hear leading clinicians and scientists on the epidemiology, pathogenesis, genomics and lifestyle challenges of EAO-CRC.
The course also included lectures as well as workshops and panel discussions designed to facilitate multidisciplinary consensus regarding the priorities of EAO-CRC prevention, clinical care and research moving forward.
Medical Decision Making associated with Clinical test interpretations. Depending on the situation one should get a second test to confirm the result of the first one; or one should move on to the treatment phase.
Presentation by Daniel Simões, HIV in Europe, Portugal , at AIDS 2018 conference during the joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
A review of breast cancer in Saudi Arabia with an update on all aspects of breast cancer management including Diagnosis, Family History, Surgery (& Reconstructive Surgery), Sentinel Node Biopsy and Adjuvant Chemo, Radio and Hormone Therapy.
Strengthening ncd surveillance in malaysia, asean ncd forum 2013Feisul Mustapha
Zainal Ariffin Omar and Feisul Idzwan Mustapha. Strengthening NCD Surveillance in Malaysia. 15 September 2013. Working paper presented at the ASEAN Regional Forum on NCDs. Manila, Philippines.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
More Related Content
Similar to Clinical Quality Performance Indicators June 2018
What is the current situation of HIV in Europe and Central Asia?
How can we more effectively prevent new infections?
Presentation by Anastasia Pharris,
European Centre for Disease Prevention and Control (ECDC)
at Glasgow HIV Drug Therapy Conference
28 October 2018
Interesting things about alcohol and other drugs - October 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
In the final ELC West of England series, we look back at the data we've collected over the past two years to show us how we, as a collaborative, have progressed.
As part of the IFPRI Egypt Seminar in partnership with the National Nutrition Committee: "the 100 million healthy lives initiative: Food availability, access and consumption patterns in Egypt"
Presentation by Teymur Noori, ECDC, at AIDS 2018 conference during teh joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
The Early Age Onset (EAO) Colorectal Cancer (CRC) Summit was a novel meeting designed for Early Age Onset (EAO) colorectal cancer (CRC) survivors, affected families as well as physicians and scientists who were interested in advancing their understanding of the rapidly increasing incidence of rectal and colon cancer among young adults under 50 years of age.
Co-hosted by the Colon Cancer Challenge Foundation and the CME office of Memorial Sloan Kettering Cancer Center the program provided an opportunity to hear leading clinicians and scientists on the epidemiology, pathogenesis, genomics and lifestyle challenges of EAO-CRC.
The course also included lectures as well as workshops and panel discussions designed to facilitate multidisciplinary consensus regarding the priorities of EAO-CRC prevention, clinical care and research moving forward.
Medical Decision Making associated with Clinical test interpretations. Depending on the situation one should get a second test to confirm the result of the first one; or one should move on to the treatment phase.
Presentation by Daniel Simões, HIV in Europe, Portugal , at AIDS 2018 conference during the joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
A review of breast cancer in Saudi Arabia with an update on all aspects of breast cancer management including Diagnosis, Family History, Surgery (& Reconstructive Surgery), Sentinel Node Biopsy and Adjuvant Chemo, Radio and Hormone Therapy.
Strengthening ncd surveillance in malaysia, asean ncd forum 2013Feisul Mustapha
Zainal Ariffin Omar and Feisul Idzwan Mustapha. Strengthening NCD Surveillance in Malaysia. 15 September 2013. Working paper presented at the ASEAN Regional Forum on NCDs. Manila, Philippines.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
2. Prenatal Care
Access to Prenatal Care
Goal: 90% of pregnant women will enter prenatal care in the
1st trimester of pregnancy
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (90%) 2016 National
(74%)
2015 (71%) 2016 (93%) 2017 (100%) Q1 2018 (100%)
Prenatal Health
3. Low Birth Weights
Goal: 0% of children will be born at low-birth weights
(<2500g)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (0%) 2016 National
(8%)
2015 (0%) 2016 (50%) 2017 (0%) Q1 2018 (0%)
Low-Birth Weights
4. Weight Assessment and Counseling for Children and Adolescents (ages 3 to 17 years)
Goal: 80% of children, ages 3 to 17, with a recorded BMI percentile will have
documentation of counseling for nutrition and physical activity during the
measurement year that is appropriate for the BMI.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (80%) 2016 National
(63%)
2015 (73%) 2016 (81%) 2017 (64%) Q1 2018 (76%)
Weight Assessment and Counseling in Children
Preventative Health Maintenance
5. Adult Weight Screening and Follow-Up Care
Goal: 88% of patients 18 and older will have a BMI recorded during the most
recent visit or within six months of the most recent visit and will have a
follow-up plan documented when the BMI is outside of normal parameters.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (88%) 2016 National
(62%)
2015 (90%) 2016 (83%) 2017 (70%) Q1 2018 (86%)
Adult Weight Screening and Follow-Up Care
6. Tobacco Use Screening and Cessation Intervention
Goal: 90% of patients 18 years and older who were screened for tobacco use
one or more times within the past 24 months will receive cessation
counseling intervention if identified as a tobacco user.
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
Goal (90%) 2016 National
(85%)
2015 (83%) 2016 (89%) 2017 (89%) Q1 2018 (89%)
Tobacco Use and Cessation Intervention
7. Colorectal Cancer Screening
Goal: 42% of adults 50-75 years of age will have appropriate screening for
colorectal cancer.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (42%) 2016 National
(40%)
2015 (31%) 2016 (27%) 2017 (41%) Q1 2018 (71%)
Colorectal Cancer Screening
8. Cervical Cancer Screening
Goal: 70% of women 23-64 years of age will receive one or more pap tests to
screen for cervical cancer. Women age 23-64 who had a cervical cancer
(cytology) every 3 years & women age 30-64 years of age who had cervical
cytology/ human papillomavirus co-testing every 5 years.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (70%) 2016 National
(54%)
2015 (64%) 2016 (51%) 2017 (67%) Q1 2018 (63%)
Cervical Cancer Screening
9. Childhood Immunizations
Goal: 60% of children two years of age who had appropriate immunizations.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (60%) 2016 National
(43%)
2015 (81%) 2016 (45%) 2017 (47%) Q1 2018 (42%)
Childhood Immunizations
10. Oral Health Sealants
Goal: 70% of children 6 to 9 years, at moderate to high risk of caries will receive
dental sealants.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (70%) 2016 National
(49%)
2015 (42%) 2016 (81%) 2017 (54%) Q1 2018 (63%)
Oral Health Sealants
11. Depression Screening and Follow-Up
Goal: 75% of patients 12 years and older screened for clinical depression and
found positive on screening for depression will have a follow-up plan
documented on the date of the positive screen.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (75%) 2016 National
(60%)
2015 (39%) 2016 (56%) 2017 (63%) Q1 2018 (77%)
Depression Screening and Follow-Up
12. Asthma Treatment
Goal: 84% of patients with having persistent asthma were prescribed the
appropriate medications.
Chronic Disease Management
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
Goal (84%) 2016 National
(87%)
2015 (48%) 2016 (76%) 2017 (93%) Q1 2018 (71%)
Asthma Treatment
13. Coronary Artery Disease and Lipid Lowering Therapy
Goal: 80% of patients 18 years and older with a diagnosis of Coronary Artery
Disease (CAD) will be prescribed a lipid lowering therapy.
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
Goal (80%) 2016 National
(79%)
2015 (75%) 2016 (78%) 2017 (91%) Q1 2018 (92%)
CAD and Lipid-Lowering Therapy
14. Ischemic Vascular Disease and Use of Aspirin or Another Antithrombotic
Goal: 80% of patients 18 years and older with Ischemic Vascular Disease (IVD)
will have documentation of use of aspirin or another antithrombotic during
the measurement year.
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
Goal (80%) 2016 National
(78%)
2015 (73%) 2016 (78%) 2017 (83%) Q1 2018 (67%)
IVD and Treatment
15. Blood Pressure Control
Goal: 72% of patients 18-85 years of age will have blood pressure adequately
controlled (<140/90).
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
Goal (72%) 2016 National
(62%)
2015 (67%) 2016 (67%) 2017 (67%) Q1 2018 (71%)
Blood Pressure Control
16. Diabetes Control
Goal: 22 % or less of diabetic patients will have a Hemoglobin A1C > 9.0%.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (22%) 2016 National
(32%)
2015 (24%) 2016 (25%) 2017 (26%) Q1 2018 (22%)
Diabetes Control
17. HIV Linkage into Care
Goal: 100% percent of patients diagnosed with HIV will be linked into care
within 90 days of diagnosis.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (100%) 2016 National
(83%0
2015 (100%) 2016 (100%) 2017 (100%) Q1 2018
(100%)
HIV Linkage to Care
18. HIV Testing
Goal: 25% of patients 16 to 64 years of age seen in the last 12 months will be
screen at least once in their lifetime for HIV.
Other Performance Indicators Chosen by CFHC, Inc.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (20%) 2015 (13%) 2016 (38%) 2017 (49%) Q1 2018 (38%)
HIV Testing
19. HIV and Dental Care
Goal: 25% of HIV patients will have a documented dental exam with a dentist
in the measurement year.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (25%) 2016 (19%) 2017 (26%) Q1 2018 (9%)
HIV and Dental Care
20. Migrant Seasonal Farmers Workers and Green Tobacco Sickness/Pesticide
Counseling
Goal: 55% of Migrant Season Farmworkers will receive education on green
tobacco sickness/pesticides.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (55%) 2015 (79%) 2016 (51%) 2017 (66%) Q1 2018 (72%)
MSFW and GTS/Pesticide Counseling
21. Breast Cancer Screening
Goal: 65% of women ages 40-64 years old will be screened for breast cancer
at least every two years.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (65%) 2015 (76%) 2016 (74%) 2017 (58%) Q1 2018 (61%)
Breast Cancer Screening
22. Hepatitis C Screening
Goal: 30% of adults born between the years 1945-1965 will be screened for
Hepatitis C.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (30%) 2016 (17%) 2017 (58%) Q1 2018 (54%)
Hepatitis C Screening
23. Diabetes and Foot Exams
Goal: 65% of diabetic patients will receive a foot exam annually.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (65%) 2015 (63%) 2016 (31%) 2017 (32%) Q1 2018 (34%)
Diabetes and Foot Exams
24. Diabetes and Retinal Eye Exams
Goal: 35% of diabetics will have a retinal eye exam.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (35%) 2015 (11%) 2016 (13%) 2017 (18%) Q1 2018 (20%)
Diabetes and Retinal Eye Exams
25. Depression and Use of the PHQ9 Tool to Monitor Treatment
Goal: 85% of the patients diagnosed with depression will have a PHQ9
completed and on file to monitor treatment outcomes.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Goal (85%) 2015 (79%) 2016 (84%) 2017 (70%) Q1 2018 (72%)
Depression and PHQ9